Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $52.4550 (-9.25%) ($52.0800 - $52.4550) on Tue. Sep. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.66% (three month average) | RSI | 23 | Latest Price | $52.4550(-9.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2% a day on average for past five trading days. | Weekly Trend | EDIT declines -6.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(69%) IWO(63%) IBUY(62%) IWC(62%) IWM(59%) | Factors Impacting EDIT price | EDIT will decline at least -2.83% in a week (0% probabilities). VIXM(-33%) UUP(-16%) VXX(-12%) TBT(-8%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.83% (StdDev 5.66%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $44.96(-14.29%) | Resistance Level | $62.19 | 5 Day Moving Average | $57.34(-8.52%) | 10 Day Moving Average | $58.91(-10.96%) | 20 Day Moving Average | $62.19(-15.65%) | To recent high | -28% | To recent low | 33.6% | Market Cap | $3.258b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |